Surmodics, Inc.
WHO'M
ai
Digital Profiler. Simply click the AI button
FIGI: BBG000BZ2QG2
SRDX
Surmodics, Inc.
GICS: -
·
Sector: Healthcare
·
Sub-Sector: Medical Devices
NAME
Surmodics, Inc.
ISIN
US8688731004
TICKER
SRDX
MIC
XNAS
REUTERS
SRDX.OQ
BLOOMBERG
SRDX US
Financial Intelligence
FOR INVESTORS
FOR TRADERS
Securities Trading
Warrants
The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available to you here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by BusinessWire.
Mon, 03.02.2025
Surmodics
US8688731004
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced the successful early clinical use of its Pounce™ XL Thrombectomy System. The Pounce XL Thrombectomy System received U.S. Food and Drug Administration (FDA) 510(k) clearance in September 2024, and is...
Surmodics
Thu, 30.01.2025
Surmodics
US8688731004
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its first quarter ended December 31, 2024.
First Quarter Fiscal 2025 Financial Summary
Total Revenue of $29.9 million, a decrease of 2% year-over-year
Total Revenue exclu...
Surmodics
Wed, 06.11.2024
Surmodics
US8688731004
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its fourth quarter and fiscal year ended September 30, 2024.
Fourth Quarter Fiscal 2024 Financial Summary
Total Revenue of $33.2 million, an increase of 19% year-over-year
T...
Surmodics
Wed, 30.10.2024
Surmodics
US8688731004
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that early results of a subset of 60 real-world acute, subacute, and chronic limb ischemia patients from its PROWL registry study were presented by Dr. Dean Ferrera at the 36th Annual TCT Symposium ...
Surmodics
Tue, 01.10.2024
Surmodics
US8688731004
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Pounce™ XL Thrombectomy System.
The Pounce XL Thrombectomy System is indicated for the non-surgical removal of thrombi and emboli from the perip...
Surmodics
Information on product placements
SMART * AD
P R O D U C T S U G G E S T I O N S
